ketoconazole has been researched along with Kidney Neoplasms in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketoconazole (KTZ) is an FDA approved anti-fungal medication which has been shown to suppress exosome biogenesis and secretion, yet its role in ccRCC has not been identified." | 1.62 | Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma. ( Abdel-Mageed, AB; Barata, PC; Boulares, AH; Datta, A; Greenberg, JW; Kim, H; Krane, LS; Moustafa, AA, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenberg, JW | 1 |
| Kim, H | 1 |
| Moustafa, AA | 1 |
| Datta, A | 1 |
| Barata, PC | 1 |
| Boulares, AH | 1 |
| Abdel-Mageed, AB | 1 |
| Krane, LS | 1 |
1 other study available for ketoconazole and Kidney Neoplasms
| Article | Year |
|---|---|
Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Repositioning; Drug Resistance, Neoplasm; Drug | 2021 |